Literature DB >> 18595878

Characteristics of HIV-1-associated Kaposi's sarcoma among women and men in South Africa.

A Mosam1, H P Hurkchand, E Cassol, T Page, S Cassol, U Bodasing, J Aboobaker, H Dawood, G H Friedland, H M Coovadia.   

Abstract

Despite the increase of HIV-1-associated Kaposi's sarcoma (KS), little is known about HIV-associated KS in the African setting, particularly among women. A descriptive study of the demographic, clinical, immunological and virological features of AIDS-associated KS from KwaZulu-Natal, South Africa was undertaken. Consecutively, recruited patients were clinically staged; CD4/CD8 cell counts, HIV-1 viral loads and clinical parameters were evaluated. Of the 152 patients (77 male and 75 female) 99% were black. Females were significantly younger (P = 0.02) and had poorer disease prognosis (odds ratio [OR] = 2.7, 95% confidence interval [CI] = 1.4-5.4, P = 0.003) and were more likely to have extensive cutaneous KS when compared with males (OR = 3.1, 95% CI = 1.4-6.7, P = 0.003). One-third of patients had coexisting HIV-related disease, most commonly tuberculosis, and these were more frequent in females (56.7 vs. 43.3%). In conclusion, HIV-associated KS in South Africans has an equal female-to-male ratio. Females are younger and have more severe disease than males.

Entities:  

Mesh:

Year:  2008        PMID: 18595878     DOI: 10.1258/ijsa.2008.007301

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  11 in total

1.  Kaposi's sarcoma: a 10-year experience with 248 patients at a single tertiary care hospital in Tanzania.

Authors:  Phillipo L Chalya; Fidelis Mbunda; Peter F Rambau; Hyasinta Jaka; Nestory Masalu; Mariam Mirambo; Martha F Mushi; Samuel E Kalluvya
Journal:  BMC Res Notes       Date:  2015-09-15

Review 2.  Treatment strategies for Kaposi sarcoma in sub-Saharan Africa: challenges and opportunities.

Authors:  Susan E Krown
Journal:  Curr Opin Oncol       Date:  2011-09       Impact factor: 3.645

3.  Evaluation of a Predictive Staging Model for HIV-Associated Kaposi Sarcoma in Uganda.

Authors:  Fred Okuku; Elizabeth M Krantz; James Kafeero; Moses R Kamya; Jackson Orem; Corey Casper; Warren Phipps
Journal:  J Acquir Immune Defic Syndr       Date:  2017-04-15       Impact factor: 3.731

4.  Burden, characteristics, management and outcomes of HIV-infected patients with Kaposi's sarcoma in Zomba, Malawi.

Authors:  E Mwinjiwa; P Isaakidis; R Van den Bergh; A D Harries; K D Bezanson; T Beyene; C Thompson; M Joshua; H Akello; M van Lettow
Journal:  Public Health Action       Date:  2013-06-21

5.  A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa.

Authors:  Anisa Mosam; Fahmida Shaik; Thomas S Uldrick; Tonya Esterhuizen; Gerald H Friedland; David T Scadden; Jamila Aboobaker; Hoosen M Coovadia
Journal:  J Acquir Immune Defic Syndr       Date:  2012-06-01       Impact factor: 3.731

6.  Changes in the pattern of Kaposi's sarcoma at Ocean Road Cancer Institute in Tanzania (2006-2011).

Authors:  Lia Koski; Twalib Ngoma; Julius Mwaiselage; Lynne Le; Amr S Soliman
Journal:  Int J STD AIDS       Date:  2014-07-30       Impact factor: 1.359

7.  Survival of patients with Kaposi's sarcoma in the South African antiretroviral treatment era: A retrospective cohort study.

Authors:  M M Sengayi; D Kielkowski; M Egger; L Dreosti; J Bohlius
Journal:  S Afr Med J       Date:  2017-09-22

8.  Gender differences in clinical presentation and outcomes of epidemic Kaposi sarcoma in Uganda.

Authors:  Warren Phipps; Fred Ssewankambo; Huong Nguyen; Misty Saracino; Anna Wald; Lawrence Corey; Jackson Orem; Andrew Kambugu; Corey Casper
Journal:  PLoS One       Date:  2010-11-12       Impact factor: 3.240

9.  Excellent clinical outcomes and retention in care for adults with HIV-associated Kaposi sarcoma treated with systemic chemotherapy and integrated antiretroviral therapy in rural Malawi.

Authors:  Michael E Herce; Noel Kalanga; Emily B Wroe; James W Keck; Felix Chingoli; Listern Tengatenga; Satish Gopal; Atupere Phiri; Bright Mailosi; Junior Bazile; Jason A Beste; Shekinah N Elmore; Jonathan T Crocker; Jonas Rigodon
Journal:  J Int AIDS Soc       Date:  2015-05-29       Impact factor: 5.396

10.  Randomized Phase IIA Trial of Gemcitabine Compared With Bleomycin Plus Vincristine for Treatment of Kaposi's Sarcoma in Patients on Combination Antiretroviral Therapy in Western Kenya.

Authors:  Naftali W Busakhala; Paul J Waako; Matthew Robert Strother; Alfred Kipyegon Keter; Gabriel Kimutai Kigen; Fredrick Chite Asirwa; Patrick J Loehrer
Journal:  J Glob Oncol       Date:  2018-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.